131I-TLX-101

Iodine-131 TLX-101 · Telix Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 131I-TLX-101, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) [Phase 1]